December 2020

Palforzia from Aimmune Therapeutics has received approval from the European Commission (EC) for the treatment of a peanut allergy. The EC has approved Palforzia for use in children aged 4 to 17 years with a confirmed diagnosis of peanut…

It's a world full of peanuts - or at least it can feel that way for kids with peanut allergies. But a new study by researchers at the University of British Columbia and BC Children's Hospital gives hope to parents and children who…